Swinburne researchers investigate effects of medicinal cannabis on drivers

The study will be conducted on-site at Swinburne's driving simulator facilities within the Drugs and Driving Research unit.
In summary
- Dr Amie Hayley and Professor Luke Downey from Swinburne’s Drugs and Driving Research Unit have received funding from the federal government’s Road Safety Innovation Fund
- This study will be the first to use innovative technologies to examine the effect of medicinal cannabis products available in Australia on driving ability
- As medicinal cannabis becomes increasingly available, the researchers say solutions to identify and reduce cannabis impaired driving are urgently needed to promote traffic safety
A Swinburne study into the effects on medical cannabis on driving ability has received $345,951 in funding from the federal government’s Road Safety Innovation Fund. Led by Dr Amie Hayley and Professor Luke Downey from the Centre for Human Psychopharmacology, it will also investigate how we can use technology to measure driving impairment.
The study is the first of its kind and will be conducted within Swinburne’s Drugs and Driving Research unit, which is led by Professor Downey.
‘We are grateful for this grant, and especially for the opportunity to further our research in this space,’ says Professor Downey. ‘It is critical to quantify the potential risk these road users take when they get behind the wheel and develop methods to protect these vulnerable patients, as well as all road users.’
Filling a gap in knowledge
Many Australian consumers of medicinal cannabis access products that contain delta-9-tetrahydrocannabinol, better known as THC, which is a controlled drug under the Australian Poisons Standard, which provides a uniform approach to control the availability and accessibility of substances that can be used as ingredients in medicine.
‘A controlled drug is a medicine that may only be prescribed by an authorised healthcare professional. As of February 2021, over 100,000 special access permits for medicinal cannabinoid products has been approved, a large proportion of which contains THC,’ explains Dr Hayley, who is Principal Investigator for the study.
’There is no definitive legal, clinical or road safety recommendation as to the length of time that medicinal cannabis products can be detected, nor whether the use of these products contribute to increased risk of traffic collision,’ Professor Downey adds.
Using innovative technology
‘We will conduct a program of research that examines the use of innovative technology, such as driver monitoring systems, to protect vulnerable road users who may make the mistake of operating a vehicle when the medication is impairing their ability to control the vehicle,’ says Dr Hayley.
Driver monitoring systems monitor and detect a driver’s state and collect information to make an instant assessment about their capacity to drive safely. These technologies have already been highly effective in detecting and alerting drivers who are tired or distracted by creating a sound to reengage the driver.
‘Using our high-fidelity driving simulator and eye monitoring technologies, we will test the relationship between eye movements and driver behaviour to better understand the impact of medicinal cannabis use on driving performance in patients, as well as healthy adults,’ Professor Downey explains.
‘As medicinal cannabis becomes increasingly available, solutions to identify and reduce cannabis impaired driving are urgently needed to promote traffic safety. Through our research, we hope to uncover potential solutions to mitigate the risk of road trauma for these patients and all road users,’ says Dr Hayley.
Supporting road safety
The Road Safety Innovation Fund is awarded by the federal government’s Office of Road Safety.
The fund supports innovative projects designed to reduce the number of deaths and serious injuries on Australian roads and help create a safe and sustainable road transport system for everyone. Priority areas include improving road safety in regional and remote areas, reducing driver distraction and drug driving, improving safety for vulnerable road users and supporting road safety research and initiatives specific to the Australian context.
-
Media Enquiries
Related articles
-
- Health
Is it okay to kiss your pet? The risk of animal-borne diseases is small, but real
While owning a pet is linked to numerous mental and physical health benefits, our pets can also harbour infectious diseases that can sometimes be passed on to us. For most people, the risk is low.
Tuesday 05 September 2023 -
- Health
- University
Swinburne to help drive change in Victoria’s mental health system
Swinburne is an academic partner within the Victorian Collaborative Centre for Mental Health and Wellbeing’s Adult and Older Adult Best Practice Consortium.
Thursday 10 August 2023 -
- Engineering
- Health
Do I have the right bicycle helmet and how can I tell if it’s any good? A bike helmet researcher explains
If you ride a bike and want to cut your risk of traumatic head injury, you should wear a helmet. A major Australian review of 40 different studies and 64,000 injured cyclists worldwide showed wearing a bicycle helmet reduces the risk of serious head injury by nearly 70%.
Monday 07 August 2023 -
- Student News
- Social Affairs
- University
Celebrate Pride Week at Swinburne
Swinburne has a host of activities planned to celebrate Pride Week in line with this year’s theme of Queer Intersections.
Tuesday 01 August 2023 -
- Social Affairs
Ageing in a housing crisis: growing numbers of older Australians are facing a bleak future
The collision between an ageing population and a housing crisis has left more older people in Australia enduring housing insecurity and homelessness. Our research, released today, explores how the scale of these problems among older people has grown over the past decade.
Thursday 10 August 2023